GeoVax Announces Publication of Repeat Challenge Preclinical Trial in the Journal of Virology

: GOVX ), an Atlanta-based biotechnology company developing vaccines to prevent and treat HIV/AIDS, announced today the publication of the results of a study in which non-human primates vaccinated with simian prototypes of its HIV vaccine resisted up ...

http://ift.tt/1hBN4ap